menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Comments
  • Overview

    Dr. Florin Rader reviews the results of treatment with mavacamten from the EXPLORER-LTE cohort of the MAVA-LTE study in patients with obstructive hypertrophic cardiomyopathy (HCM). 

Facebook Comments

Recommended
Details
Comments
  • Overview

    Dr. Florin Rader reviews the results of treatment with mavacamten from the EXPLORER-LTE cohort of the MAVA-LTE study in patients with obstructive hypertrophic cardiomyopathy (HCM). 

Facebook Comments

Schedule17 May 2022
Webpack App